1Petriccione PV, Wedley JR. The use of celiac plexus block in abdominall cancer pain: a review[J]. Pain Clinic, 1990,3(4):223-227.
2Evans DB, Wolff RA, Crane CH, et al. Cancer of the Pancreas[M]. Pollock RE, Doroshow JH, Khayat D, et al. UICC manual of Clinical Oncology. New Jersey: John Wiley & Sons,2004:465-485.
3World Health Organization. Handbook for reporting resuits of cancer treatment. World Health Organization[R]. Genvae, 1976:16-21.
4Kongsgaard UE, Bjorgo S, HauserM. Neurolytic blocks for cancer pain-still an useful therapeutic strategy [J]. Tidsskr NorLaegeforen,2004,124(4):481-483.
5Kita Y, Tanaka T, Yoshida S, et al. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus mon-key model [J]. Vaccine,2005,23(1718): 2132.
7Jain PN, Shrikhande SV, Myatra SN, et al. Neurolytic celiac plexus block: a better alternative to opioid treatment in upper abdominal malignancies: an Indian experience[J]. Pain Palliat Care Pharmacother,2005,19(3):15- 20.
8Fitzgibbon DR, Schmiedl UP, Sinanan MN. Computed tomography -guided neurolytic celiac plexus block with alcohol complicated by superior mesenterie venous thrombosis[J]. Pain,2001,92(1-2):307-310.
10Kitoh T, Tanaka S, Ono K, et al. Combined neurolytic block of celiac, inferior mesenteric, and superior hypogastric plexuses for incapacitating abdominal and/or pelvic cancer pain[J]. Anesth,2005,19(4):328-332.
